SCHEMBL270579

SCHEMBL270579

[CH2]CCCC(O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7849858 0.92
SCHEMBL3296343 0.89 THRB (0.46)
SCHEMBL3677838 0.89 THRB (0.46)
SCHEMBL9148231 0.89 THRB (0.46)
SCHEMBL270137 0.81
SCHEMBL100643 0.81 THRB (0.62)
SCHEMBL1164867 0.81 THRB (0.62)
SCHEMBL6358420 0.80 PTPN1 (0.37)
SCHEMBL7593215 0.80
SCHEMBL18280923 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104788492-A Oxidized lipid compounds and uses thereof VASCULAR BIOGENICS LTD 2015-07-22 CN claimed
EP-2826370-A2 Oxidized lipid compounds and uses thereof Vascular Biogenics Ltd. (IL) 2015-01-21 EP claimed
EP-2826369-A2 Oxidized lipid compounds and uses thereof Vascular Biogenics Ltd. (IL) 2015-01-21 EP claimed
EP-2348866-B1 OXIDIZED LIPID COMPOUNDS AND USES THEREOF VASCULAR BIOGENICS LTD (IL) 2015-01-07 EP claimed
EP-2456792-B1 PROCESS FOR THE PRODUCTION OF CONDENSATION POLYMERS VIA IN-REACTOR CHAIN EXTENSION AND PRODUCTS THEREOF BASF CORP (US) 2014-03-12 EP claimed
US-20130203707-A1 Oxidized Lipid Compounds and Uses Thereof VASCULAR BIOGENICS LTD. (IL) 2013-08-08 US claimed
CN-102271517-A oxidized lipid compounds and uses thereof 2011-12-07 CN claimed
US-20110207703-A1 OXIDIZED LIPID COMPOUNDS AND USES THEREOF VASCULAR BIOGENICS LTD. (IL) 2011-08-25 US claimed
WO-2010052718-A9 OXIDIZED LIPID COMPOUNDS AND USES THEREOF VASCULAR BIOGENICS LTD. (IL) 2011-06-16 WO claimed
US-20060173058-A1 Kcnq channel modulating compounds and their pharmaceutical use NEUROSEARCH A/S (DK) 2006-08-03 US claimed
US-5492821-A DIAGNOSTICS, FOOD INDUSTRY CARGILL, INC. (US) 1996-02-20 US claimed
EP-0367812-B1 PROCESS FOR PREPARING WATER-DISPERSABLE POLYURETHANE/ACRYLIC POLYMER COMPOSITIONS JOHNSON & SON INC S C (US) 1995-03-01 EP claimed
EP-0513332-A4 CONJUGATES OF POLY(VINYLSACCHARIDE) WITH PROTEINS FOR THE STABILIZATION OF PROTEINS 1993-03-17 EP claimed
EP-0513332-A1 CONJUGATES OF POLY(VINYLSACCHARIDE) WITH PROTEINS FOR THE STABILIZATION OF PROTEINS CARGILL, INCORPORATED (US) 1992-11-19 EP claimed
WO-1992008790-A1 CONJUGATES OF POLY(VINYLSACCHARIDE) WITH PROTEINS FOR THE STABILIZATION OF PROTEINS CARGILL, INCORPORATED (US) 1992-05-29 WO claimed
US-5082845-A Gastrointestinal HOECHST JAPAN LIMITED (JP) 1992-01-21 US claimed
EP-0330031-B1 THERAPEUTIC AGENTS FOR THE TREATMENT OF PEPTIC ULCER DISEASE HOECHST JAPAN LIMITED (JP) 1991-12-11 EP claimed
EP-0330031-A1 Therapeutic agents for the treatment of peptic ulcer disease HOECHST JAPAN LIMITED (JP) 1989-08-30 EP claimed
US-4616020-A TREATING OBSTRUCTIVE RESPIRATORY DISEASES HOECHST AKTIENGESELLSCHAFT (DE) 1986-10-07 US claimed
EP-0075850-B1 PHARMACEUTICAL PREPARATIONS CONTAINING VICINAL DIHYDROXYALKYL XANTHINES, PROCESS FOR THE PREPARATION OF THE XANTHINES AND THE APPROPRIATE INTERMEDIATES THEREFOR HOECHST AKTIENGESELLSCHAFT (DE) 1985-12-18 EP claimed